Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds-News

T2 Biosystems Inc. (TTOO): Billionaire Julian Robertson’s Tiger Management Significantly Increases Its Stake

Published on July 11, 2016 at 4:59 pm by Insider Monkey Staff in Hedge Funds, News

Billionaire Julian Robertson‘s Tiger Management recently filed a Form 13G with the Securities and Exchange Commission in which it reported increasing its stake in T2 Biosystems Inc. (NASDAQ:TTOO) to 1.26 million common shares, which account for 5.17% of the company’s outstanding stock. The stake was increased from 552,255 common shares, a position which Tiger Management disclosed in its latest 13F filing for the reporting period of March 31.

T2 Biosystems is a biotech company that works on creating innovative diagnostic products, and which was proclaimed the 34th-smartest company of 2016, according to MIT Technology’s annual review. Year-to-date, the company’s stock is down by 51.37%. For the first quarter of 2016, T2 Biosystems (NASDAQ:TTOO) reported a loss per share of $0.55, slightly missing estimates of a loss per share of $0.54. The company’s revenue came in at $1.1 million for the quarter, in-line with estimates. Recently, Cantor Fitzgerald reiterated its ‘Buy’ rating on the stock, while Janney Montgomery Scott reiterated its ‘Hold’ rating.

According to our hedge fund database, T2 Biosystems (NASDAQ:TTOO) has seen a decrease in the number of investors long the stock, as six funds reported such positions in the company as of the end of March, down from 11 a quarter earlier. The most valuable position was held by Dennis Purcell’s Aisling Capital, worth close to $27.9 million, while the second-largest position was reported by Richard Mashaal of RIMA Senvest Management, being valued at $12.9 million. Some other investors that held long positions included Steve Cohen’s Point72 Asset Management and Hal Mintz’s Sabby Capital.Julian Robertson

Among investors who dumped T2 Biosystems (NASDAQ:TTOO) in the first quarter were Israel Englander’s Millennium Management, which sold off its position worth close to $2.8 million in shares, while Wojciech Uzdelewicz’s Espalier Global Management dropped a position worth close to $0.3 million.

You can access the original SEC filing by clicking here.

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Tiger Partners Trading 0 1,256,638 0 1,256,638 1,256,638 5.17%
Tiger Partners 0 1,256,638 0 1,256,638 1,256,638 5.17%
Tiger Partners GP 0 1,256,638 0 1,256,638 1,256,638 5.17%
Tiger Management 0 1,256,638 0 1,256,638 1,256,638 5.17%
The Julian H. Robertson, Jr. Revocable Trust 0 1,256,638 0 1,256,638 1,256,638 5.17%
Julian H. Robertson, Jr 0 1,256,638 0 1,256,638 1,256,638 5.17%

Follow Julian Robertson's Tiger Management

Page 1 of 12 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
T2 Biosystems, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
89853L104
(CUSIP Number)
June 29, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[_]  Rule 13d-1(d)
__________
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 2 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Tiger Partners Trading LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 3 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Tiger Partners, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 4 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Tiger Partners GP, L.L.C.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 5 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Tiger Management L.L.C.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 6 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
The Julian H. Robertson, Jr. Revocable Trust
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 7 of 12 – SEC Filing

CUSIP No
89853L104
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Julian H. Robertson, Jr.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,256,638
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,256,638
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,638
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN, HC

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 8 of 12 – SEC Filing

CUSIP No
89853L104
Item 1.
(a).
Name of Issuer:
T2 Biosystems, Inc.
(b).
Address of Issuer’s Principal Executive Offices:
101 Hartwell Avenue
Lexington, MA 02421
Item 2.
(a).
Name of Person Filing:
Tiger Partners Trading LLC
Tiger Partners, L.P.
Tiger Partners GP, L.L.C.
Tiger Management L.L.C.
The Julian H. Robertson, Jr. Revocable Trust
Julian H. Robertson, Jr.
(b).
Address of Principal Business Office, or if None, Residence:
101 Park Avenue
New York, NY 10178
(c).
Citizenship:
Tiger Partners Trading LLC – Delaware
Tiger Partners, L.P. – Delaware
Tiger Partners GP, L.L.C. – Delaware
Tiger Management L.L.C. – Delaware
The Julian H. Robertson, Jr. Revocable Trust – Delaware
Julian H. Robertson, Jr. – United States of America
(d).
Title of Class of Securities:
Common Stock, $0.001 par value
(e).
CUSIP Number:
89853L104
Item 3.
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 9 of 12 – SEC Filing

Item 4.
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned:
1,256,638 shares deemed beneficially owned by Tiger Partners Trading LLC
1,256,638 shares deemed beneficially owned by Tiger Partners, L.P.
1,256,638 shares deemed beneficially owned by Tiger Partners GP, L.L.C.
1,256,638 shares deemed beneficially owned by Tiger Management L.L.C.
1,256,638 shares deemed beneficially owned by The Julian H. Robertson, Jr. Revocable Trust
1,256,638 shares deemed beneficially owned by Julian H. Robertson, Jr.
(b)
Percent of class:
5.17% deemed beneficially owned by Tiger Partners Trading LLC
5.17% deemed beneficially owned by Tiger Partners, L.P.
5.17% deemed beneficially owned by Tiger Partners GP, L.L.C.
5.17% deemed beneficially owned by Tiger Management L.L.C.
5.17% deemed beneficially owned by The Julian H. Robertson, Jr. Revocable Trust
5.17% deemed beneficially owned by Julian H. Robertson, Jr.
(c)
Number of shares as to which Tiger Partners Trading LLC has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638
Number of shares as to which Tiger Partners, L.P. has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638
Number of shares as to which Tiger Partners GP, L.L.C. has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638
Number of shares as to which Tiger Management L.L.C. has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638
Number of shares as to which The Julian H. Robertson, Jr. Revocable Trust has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 10 of 12 – SEC Filing

Number of shares as to which Julian H. Robertson, Jr. has:
(i)
Sole power to vote or to direct the vote
0
(ii)
Shared power to vote or to direct the vote
1,256,638
(iii)
Sole power to dispose or to direct the disposition of
0
(iv)
Shared power to dispose or to direct the disposition of
1,256,638
Item 5.
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].
N/A
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
N/A
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary.  If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
N/A
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
N/A
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
N/A
Item 10.
Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 11 of 12 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
July 8, 2016
(Date)
Tiger Partners Trading LLC
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Partners, L.P.*
/s/ Julian H. Robertson
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Partners GP, L.L.C.*
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Management L.L.C.*
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
The Julian H. Robertson, Jr. Revocable Trust*
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Trustee
Julian H. Robertson, Jr. *
/s/ Julian H. Robertson, Jr.
 Signature
*The Reporting Person specifically disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 12 of 12 – SEC Filing

Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13G dated July 8, 2016 relating to the Common Stock, $0.001 par value of T2 Biosystems, Inc. shall be filed on behalf of the undersigned.
Tiger Partners Trading LLC
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Partners, L.P.
/s/ Julian H. Robertson
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Partners GP, L.L.C.
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
Tiger Management L.L.C.
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Authorized Signatory
The Julian H. Robertson, Jr. Revocable Trust
/s/ Julian H. Robertson, Jr.
Signature

Julian H. Robertson, Jr.
 Trustee
Julian H. Robertson, Jr.
/s/ Julian H. Robertson, Jr.
 Signature
SK 79600 0010 7201829

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Show more...Show less

Related Insider Monkey Articles
Hedge Funds Are Fleeing The Sinking T2 Biosystems Inc (TTOO)Latest Moves Show Hedgies Are Not Giving Up On These 3 Cratered Stocks
Why These 5 Stocks Are Tumbling Today: LendingClub (LC), Lannett (LCI), More...